These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 23559710)

  • 21. The diagnostic role of (18)F-FDG PET for primary central nervous system lymphoma.
    Yamaguchi S; Hirata K; Kobayashi H; Shiga T; Manabe O; Kobayashi K; Motegi H; Terasaka S; Houkin K
    Ann Nucl Med; 2014 Aug; 28(7):603-9. PubMed ID: 24743915
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dual-time point
    Parghane RV; Basu S
    Semin Nucl Med; 2017 Jul; 47(4):373-391. PubMed ID: 28583277
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Role of Dual-Phase FDG PET/CT in the Diagnosis and Follow-Up of Brain Tumors.
    Özütemiz C; Neil EC; Tanwar M; Rubin NT; Ozturk K; Cayci Z
    AJR Am J Roentgenol; 2020 Oct; 215(4):985-996. PubMed ID: 32841063
    [No Abstract]   [Full Text] [Related]  

  • 24. A comparison study of (11)C-methionine and (18)F-fluorodeoxyglucose positron emission tomography-computed tomography scans in evaluation of patients with recurrent brain tumors.
    Sharma R; D'Souza M; Jaimini A; Hazari PP; Saw S; Pandey S; Singh D; Solanki Y; Kumar N; Mishra AK; Mondal A
    Indian J Nucl Med; 2016; 31(2):93-102. PubMed ID: 27095856
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metabolic changes in breast cancer on dual-time-point
    Kim HO; Kim BS; Kang SY; Bang JI; An J; Kim JH; Yoon HJ
    Ann Nucl Med; 2020 Dec; 34(12):942-951. PubMed ID: 32974848
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Semi-quantitative analysis of
    Ravikanth R; Singh JK
    World J Nucl Med; 2020; 19(4):347-352. PubMed ID: 33623503
    [No Abstract]   [Full Text] [Related]  

  • 27. Glucose-corrected standardized uptake value in the differentiation of high-grade glioma versus post-treatment changes.
    Nozawa A; Rivandi AH; Kanematsu M; Hoshi H; Piccioni D; Kesari S; Hoh CK
    Nucl Med Commun; 2015 Jun; 36(6):573-81. PubMed ID: 25714806
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessment of combination of contrast-enhanced magnetic resonance imaging and positron emission tomography/computed tomography for evaluation of ovarian masses.
    Tsuboyama T; Tatsumi M; Onishi H; Nakamoto A; Kim T; Hori M; Sakane M; Hori Y; Morii E; Hatazawa J; Tomiyama N
    Invest Radiol; 2014 Aug; 49(8):524-31. PubMed ID: 24637584
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Correlation of 6-18F-fluoro-L-dopa PET uptake with proliferation and tumor grade in newly diagnosed and recurrent gliomas.
    Fueger BJ; Czernin J; Cloughesy T; Silverman DH; Geist CL; Walter MA; Schiepers C; Nghiemphu P; Lai A; Phelps ME; Chen W
    J Nucl Med; 2010 Oct; 51(10):1532-8. PubMed ID: 20847166
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of (18F)FDG PET/CT and (68Ga)DOTATATE PET/CT imaging methods in terms of detection of histological subtype and related SUVmax values in patients with pulmonary carcinoid tumors.
    Komek H; Can C; Urakçi Z; Kepenek F
    Nucl Med Commun; 2019 May; 40(5):517-524. PubMed ID: 30694875
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The value of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography for staging of primary extranodal head and neck lymphomas.
    Schrepfer T; Haerle SK; Strobel K; Schaefer N; Hälg RA; Huber GF
    Laryngoscope; 2010 May; 120(5):937-44. PubMed ID: 20422687
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The clinical efficacy of (18)F-FDG-PET/CT in benign and malignant musculoskeletal tumors.
    Shin DS; Shon OJ; Han DS; Choi JH; Chun KA; Cho IH
    Ann Nucl Med; 2008 Aug; 22(7):603-9. PubMed ID: 18756363
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnostic accuracy of
    He Q; Zhang L; Zhang B; Shi X; Yi C; Zhang X
    BMC Cancer; 2019 Apr; 19(1):332. PubMed ID: 30961564
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Optimal cutoff levels of F-18 fluorodeoxyglucose uptake in the differentiation of low-grade from high-grade brain tumors with PET.
    Delbeke D; Meyerowitz C; Lapidus RL; Maciunas RJ; Jennings MT; Moots PL; Kessler RM
    Radiology; 1995 Apr; 195(1):47-52. PubMed ID: 7892494
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Value of dual-time-point (18)F-fluorodeoxyglucose integrated positron emission and computed tomography in differentiation of malignant from benign gastrointestinal diseases].
    Xu XX; Cheng J; Xu WG; Dai D; Song XY; Ma WC; Zhu L; Zhu X
    Zhonghua Zhong Liu Za Zhi; 2012 May; 34(5):364-8. PubMed ID: 22883458
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Qualitative analysis of spinal intramedullary lesions using PET/CT.
    Naito K; Yamagata T; Arima H; Abe J; Tsuyuguchi N; Ohata K; Takami T
    J Neurosurg Spine; 2015 Nov; 23(5):613-619. PubMed ID: 26230418
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 11C-methionine (MET) and 18F-fluorothymidine (FLT) PET in patients with newly diagnosed glioma.
    Hatakeyama T; Kawai N; Nishiyama Y; Yamamoto Y; Sasakawa Y; Ichikawa T; Tamiya T
    Eur J Nucl Med Mol Imaging; 2008 Nov; 35(11):2009-17. PubMed ID: 18542957
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Simultaneous whole body (18)F-fluorodeoxyglucose positron emission tomography magnetic resonance imaging for evaluation of pediatric cancer: Preliminary experience and comparison with (18)F-fluorodeoxyglucose positron emission tomography computed tomography.
    Pugmire BS; Guimaraes AR; Lim R; Friedmann AM; Huang M; Ebb D; Weinstein H; Catalano OA; Mahmood U; Catana C; Gee MS
    World J Radiol; 2016 Mar; 8(3):322-30. PubMed ID: 27028112
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Decreased brain FDG uptake in patients with extensive non-Hodgkin's lymphoma lesions.
    Hanaoka K; Hosono M; Shimono T; Usami K; Komeya Y; Tsuchiya N; Yamazoe Y; Ishii K; Tatsumi Y; Sumita M
    Ann Nucl Med; 2010 Dec; 24(10):707-11. PubMed ID: 20824395
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Utility of FDG-PETCT and magnetic resonance spectroscopy in differentiating between cerebral lymphoma and non-malignant CNS lesions in HIV-infected patients.
    Westwood TD; Hogan C; Julyan PJ; Coutts G; Bonington S; Carrington B; Taylor B; Khoo S; Bonington A
    Eur J Radiol; 2013 Aug; 82(8):e374-9. PubMed ID: 23578921
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.